Please assess the completion status of the following clinical trial:

Trial Title: The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA Op Het Herstel Na Anesthesie Bij Kinderen).

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Written informed consent of parents/guardians~* Age ≥6 months and ≤12 years~* Surgical procedure requiring GA supplemented with caudal analgesia~* Ability of the parents/guardians to communicate in Dutch~Exclusion Criteria:~* Primary exclusion criteria~* Withdrawal of informed consent~* (Chronic) use of drugs influencing the electroencephalogram~* Use of premedication~* Known intolerance for sevoflurane~* Parents/guardians unable to communicate in Dutch~* Secondary exclusion criteria~* Protocol violation~* Data registration failure

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): In patients randomised to the control group, sevoflurane will be titrated according to a Minimal Alveolar Concentration (MAC) of 0.9 respectively an end tidal sevoflurane concentration of 2.3% based on standard practice in our paediatric anaesthesia department.
- Treatment (Type: EXPERIMENTAL): In patients randomised to the intervention group of the trial, the anaesthetic agent sevoflurane will be titrated according to the typical DSA pattern for general anaesthesia with sevoflurane, provided by the Narcotrend

Based on this trial design, predict the completion outcome and termination type (if applicable).